Exercise-based Cardiac Rehabilitation for Patients with Atrial Fibrillation Receiving Catheter Ablation

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The investigators aim to conduct a pilot randomised controlled trial (RCT) with embedded feasibility study to evaluate an exercise-based cardiac rehabilitation (ExCR) programme when delivered to patients with atrial fibrillation on the waiting list for catheter ablation. Our overall objective is to test the feasibility and acceptability of an evidence-based ExCR intervention prior to evaluation in a future randomized controlled trial (RCT).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Participant is willing and able to give informed consent for participation in the study.

• Aged ≥18 years.

• Diagnosed with AF and on a waiting list or referred for medical treatment for symptomatic AF (eg catheter ablation).

• Is eligible and willing to take part in an ExCR programme.

Locations
Other Locations
United Kingdom
Liverpool John Moores University
RECRUITING
Liverpool
Contact Information
Primary
Benjamin Buckley, PhD
B.J.Buckley@ljmu.ac.uk
‭0151 231 2121‬
Backup
Charlotte Fitzhugh, MSc
c.fitzhugh@2023.ljmu.ac.uk
Time Frame
Start Date: 2024-08-22
Estimated Completion Date: 2025-12
Participants
Target number of participants: 60
Treatments
Experimental: Exercise-based cardiac rehabilitation
Participants will complete an 8-week-long cardiac rehabilitation programme consisting of supervised exercise sessions run by a clinical exercise physiologist and psychoeducation sessions.
No_intervention: Treatment as Usual
Participants randomised to usual care will not receive any intervention but continue with usual medical treatment for their AF as determined by their healthcare team.
Related Therapeutic Areas
Sponsors
Leads: Liverpool John Moores University
Collaborators: Liverpool Heart and Chest Hospital NHS Foundation Trust

This content was sourced from clinicaltrials.gov